UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000040145
Receipt number R000045771
Scientific Title Effects of microvascular blood flow on Skeletal muscle easy fatigue state in diabetic kidney disease patients
Date of disclosure of the study information 2020/04/30
Last modified on 2020/04/13 17:28:03

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Causes of muscle fatigue in Diabetic kidney disease patients

Acronym

Muscle fatigue test in diabetic kidney disease patients

Scientific Title

Effects of microvascular blood flow on Skeletal muscle easy fatigue state in diabetic kidney disease patients

Scientific Title:Acronym

Muscle fatigue test in diabetic kidney disease patients

Region

Japan


Condition

Condition

Diabetic kidney disease

Classification by specialty

Nephrology Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To clarify the effect of microvascular blood flow on muscle fatigue in diabetic kidney disease patients

Basic objectives2

Others

Basic objectives -Others

Correlation,Impact

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

muscle fatigue,microvascular blood flow

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Device,equipment Behavior,custom

Interventions/Control_1

Performing a dynamic fatigue task while measuring microvascular blood flow in diabetic kidney disease patients

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

40 years-old <=

Age-upper limit

65 years-old >

Gender

Male and Female

Key inclusion criteria

Person who is admitted to our hospital or consults outpatient
Patients who agreed to participate in the study
Patients who have independent walking

Key exclusion criteria

Pregnant woman
Patients with comorbidity and history of severe heart or lung disease
Patients with albuminuria less than 30mg/gCr and e-GFR90 or more
Dementia patients
Uncured cancer patients

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Daisuke
Middle name
Last name Tsuriya

Organization

Hamamatsu University Hospital

Division name

Medical University Hospital Second Internal Medicine Department

Zip code

431-3192

Address

1-20-1 Handayama, Higashi-ku, Hamamatsu city, Shizuoka, Japan

TEL

053-435-2704

Email

dtsuri@hama-med.ac.jp


Public contact

Name of contact person

1st name Yuma
Middle name
Last name Hirano

Organization

Hamamatsu University Hospital

Division name

Department of Rehabilitation

Zip code

431-3192

Address

1-20-1 Handayama, Higashi-ku, Hamamatsu city, Shizuoka, Japan

TEL

053-435-2111

Homepage URL


Email

yuma.h.pt@gmail.com


Sponsor or person

Institute

Hamamatsu University Hospital

Institute

Department

Personal name



Funding Source

Organization

International University of Health and Welfare

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor

International University of Health and Welfare

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics Committee of Hamamatsu University School of Medicine(EC HUSM)

Address

1-20-1 Handayama, Higashi-ku, Hamamatsu city, Shizuoka, Japan

Tel

053-435-2680

Email

rinri@hama-med.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

浜松医科大学医学部附属病院(静岡県)


Other administrative information

Date of disclosure of the study information

2020 Year 04 Month 30 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2020 Year 02 Month 01 Day

Date of IRB

2020 Year 03 Month 30 Day

Anticipated trial start date

2020 Year 04 Month 07 Day

Last follow-up date

2021 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2020 Year 04 Month 13 Day

Last modified on

2020 Year 04 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045771


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name